MANKIND.NS

Mankind Pharma Limited

HealthcareDrug Manufacturers - Specialty & GenericININRPeers →Country macro →

$2,380.30

Jun 15, 2026

AI Brief

Market cap

$982.52B

52w range

—

P / E

—

EPS · FY 2026

$46.28

Volume

—

Revenue · FY 2026

$142.78B

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Explain this page

Arphra AIPlain-English read on Mankind Pharma Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$2380.30

Change

+13.68%

Period high

$2583.90

Period low

$1927.40

Period start

$2093.902026-02-01

Through 2026-06-15

Fair value

Football field →

Weighted blend

$1,014.58

— vs spot

Recommendation

n/a

3 of 3 methods

Method spread

0bull0bear

±5% threshold

Candlestick · 1Y

Open in chart workstation →

MANKIND.NS

2,380+13.68%

H 2,639L 1,910MA50 2,254MA200 —Avg vol 643K

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Utilities
+1.05%
Industrials
+0.77%
Basic Materials
+0.41%
Consumer Cyclical
+0.18%
Energy
+0.16%
Consumer Defensive
-0.12%
Real Estate
-0.53%
Financial Services
-0.58%
Healthcare
-1.05%
Technology
-1.15%
Communication Services
-1.55%

Top industries (issuer's industry highlighted)

Drug Manufacturers - Specialty & Generic
-0.82%
Electronic Gaming & Multimedia
+6.46%
Independent Power Producers
+3.34%
Communication Equipment
-3.29%
Medical - Equipment & Services
+3.12%
Financial - Mortgages
+2.63%
Hardware, Equipment & Parts
-2.59%
Trucking
-2.24%
Oil & Gas Energy
+2.14%
Oil & Gas Drilling
-2.10%
Conglomerates
+2.05%
Internet Content & Information
-2.03%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for MANKIND.NS.

Peers

No peer list available for MANKIND.NS.

Total assets

$280.8B

Total debt

$63.12B

Cash & equiv

$4.83B

Operating CF

$25.16B

Free cash flow

$18.9B

Buybacks

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$142.78B	$27.31B	$19.13B	$46.28	+13.40%